Emerging trends shape South Korea’s clinical trial ecosystem and supply chains
At the upcoming Outsourcing in Clinical Trials (OCT) and Clinical Trial Supply (CTS) Korea 2025 meetings, which will take place…
All articles by Irena Maragkou
Irena Maragkou
Irena Maragkou is a Healthcare Researcher for Clinical Trials Arena and Pharmaceutical Technology based in London, UK. Irena previously worked in consulting at Deloitte’s Strategy, M&A and Analytics Department, focusing on projects in the Pharmaceutical and Healthcare Sector. She holds an MSci degree in Neuroscience from UCL.
-
-
Investor focus shifts to late-stage development in biotech, expert says
The biotech sector has faced a challenging first half of 2025, underperforming relative to the broader tech industry and the…
-
Driving digital solutions through rapid experimentation
“In the future, 30% of trial data will come from the clinic, while 70% will be sourced by decentralised clinical…
-
Strategies to optimise patient engagement and retention in clinical trials
“Failure to recruit patients for trials leads to delays in drug development, which are bad both for sponsors and patients,”…
-
Rare disease drug development in the evolving policy environment
Recent changes at the US Food and Drug Administration (FDA) have changed the circumstances for rare disease drug development, but…
-
Using AI to forge the future of rare disease clinical trials
“The biggest shifts in rare disease clinical research are occurring in platform and basket trials, which from the perspective of…
-
Driving clinical research progress through innovation and patient engagement
In September 2025, leading professionals across the biotech and pharmaceutical industries will gather and discuss solutions to exchange insights about…
-
Advancing rare disease trials by overcoming patient recruitment challenges
In September 2025, clinical development and clinical operations professionals will gather and discuss the current challenges in running clinical trials…
-
Adapting to funding and operational hurdles in today’s clinical trials landscape
Against the backdrop of geopolitical tensions and economic measures such as tariffs, which are influencing supply chains across numerous industries,…
-
Japan offers competitive edge with clinical trial landscape and SMO approach
“Japan has the second biggest market for branded drugs and is the third largest market for pharmaceuticals overall,” says Kento…